Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy
Abstract Background High Programmed death ligand 1 (PD-L1) expression are thought to be necessary to PD-1/PD-L1 axis blockades in many tumors. The aim of the study was to explore the variation of PD-L1 expression after neoadjuvant chemotherapy (NAC) in cervical squamous cell carcinoma (SCC) and its...
Main Authors: | Yun Liang, Minghua Yu, Caiyun Zhou, Xiaojun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-020-00977-1 |
Similar Items
-
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
by: Yun Liang, et al.
Published: (2018-11-01) -
Neoadjuvant Chemotherapy of Cervical Squamous Cell Carcinoma during Pregnancy: A Case Report
by: Malihe Hasanzadeh, et al.
Published: (2018-10-01) -
Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1+CD8+ and CD8+ T cells as predictive of response to neoadjuvant chemotherapy in breast cancer
by: Hongling Liang, et al.
Published: (2020-10-01) -
The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review
by: Mohammed Osman
Published: (2014-09-01) -
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)
by: Hai-Bo Sun, et al.
Published: (2020-04-01)